glp 1 class action lawsuit Chicago attorney Matt Williams discusses mounting lawsuits against makers of weight loss drugs Ozempic & Wegovy Lawsuits |

Book Now with our Registered Nurse Injectors Tab Content This is a basic text element

Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor Agonists Source In both trials, after 72 weeks of treatment, patients who received Zepbound at all three dose levels experienced a statistically significant reduction in body weight compared to those who received placebo, and greater proportions of patients who received Zepbound achieved at least 5% weight reduction compared to placebo

doi: 10.1073/pnas.80.14.4546

GLP-1R activation results in feeding suppression, while GCGR activation stimulates increased energy expenditure, adipose tissue browning, mobilization and metabolism of fat, leading to substantial body weight loss and clearance of liver fat in animal models 12,13,14,15,16,17

Im pretty sure neither Novo Nordisk (the company behind Ozempic and Wegovy) or Eli Lilly (the manufacturer of Mounjaro and Zepbound) would object to all of us having at least one indication for taking these drugs